C - Chemistry – Metallurgy – 12 – P
Patent
C - Chemistry, Metallurgy
12
P
C12P 21/08 (2006.01) A61K 39/395 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2055615
The present invention relates to the use of a non-depleting anti-CD4 monoclonal antibody for the manufacture of a medicament for the induction of a state of immunological tolerance to an antigen by a method which comprises administering said non-depleting anti-CD4 monoclonal antibody to a subject together with a non-depleting anti-CD8 monoclonal antibody to induce an immunological tolerance permissive environment within said subject by means of said antibodies in the presence of said antigen. Also, the invention relates to a pharmaceutical composition in unit dose form com- prising from 1 to 400 mg per unit dose of a non-deplet- ing anti-CD4 antibody or a non-depleting anti-CD8 anti- body together with a pharmaceutically acceptable car- rier or diluent in a form suitable for administration to a human subject.
Cobbold Stephen Paul
Waldmann Herman
Cobbold Stephen Paul
Ogilvy Renault Llp/s.e.n.c.r.l.,s.r.l.
The Wellcome Foundation Limited
Waldmann Herman
LandOfFree
Monoclonal antibodies for inducing tolerance does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibodies for inducing tolerance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibodies for inducing tolerance will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1477205